Systemic therapies for prostate cancer are likely to improve, and as they do, they will have enormous impact on the treatment of high-risk and locally advanced cancers. Further technical improvements in radiotherapy and alternative local modalities, such as cryoablation, are also likely, and will bring even more options for local control. It is certain these guidelines will continue to evolve.
|Original language||English (US)|
|Number of pages||9|
|Journal||Oncology (Williston Park, N.Y.)|
|Issue number||11 A|
|State||Published - Nov 2000|
ASJC Scopus subject areas
- Cancer Research